AFT Forsyth & Company’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,867
Closed -$229K 141
2022
Q1
$229K Buy
5,867
+7
+0.1% +$272 0.15% 139
2021
Q4
$269K Buy
5,860
+220
+4% +$10.5K 0.14% 133
2021
Q3
$267K Hold
5,640
0.14% 135
2021
Q2
$261K Sell
5,640
-140
-2% -$6.34K 0.14% 138
2021
Q1
$254K Hold
5,780
0.15% 137
2020
Q4
$237K Sell
5,780
-80
-1% -$3.12K 0.15% 135
2020
Q3
$219K Hold
5,860
0.16% 124
2020
Q2
$202K Buy
+5,860
New +$182K 0.17% 122
2020
Q1
Sell
-6,505
Closed -$226K 131
2019
Q4
$226K Hold
6,505
0.17% 129
2019
Q3
$210K Buy
6,505
+130
+2% +$4.44K 0.17% 128
2019
Q2
$219K Hold
6,375
0.18% 130
2019
Q1
$214K Buy
+6,375
New +$201K 0.19% 132
2018
Q4
Sell
-7,790
Closed -$299K 139
2018
Q3
$299K Buy
+7,790
New +$287K 0.25% 115

Other funds holding FFTY

AFT Forsyth & Company's FFTY Position: Q2 2022 in Review

AFT Forsyth & Company sold out of CapForce IBD 50 ETF (FFTY) in Q2 2022, closing a stake of 5,867 shares — an estimated $229K sold.

AFT Forsyth & Company first reported a position in FFTY in Q3 2018 and held it in 13 quarters. The position peaked at $299K in Q3 2018. 58 funds tracked by Wall St. Rank hold FFTY as of Q2 2022.

  • AFT Forsyth & Company reported no remaining CapForce IBD 50 ETF position as of Q2 2022 after selling out during the quarter.
  • AFT Forsyth & Company sold 5,867 CapForce IBD 50 ETF shares in Q2 2022, an estimated $229K.
  • AFT Forsyth & Company first reported a position in CapForce IBD 50 ETF in Q3 2018 and held it in 13 quarters.
  • AFT Forsyth & Company's CapForce IBD 50 ETF position peaked at $299K in Q3 2018.
  • 58 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2022.

Based on AFT Forsyth & Company's 13F filing for Q2 2022, filed 28 Jul 2022.